Local Anesthesia Drugs Market Overview
Local anesthesia is also called as local anesthetic, is usually a one-time injection of medicine that numbs a small area of the body, It is used for procedures such as performing a skin biopsy or breast biopsy, repairing a broken bone, or sewing up a deep cut. Propofol, etomidate, and ketamine are intravenous sedative-hypnotics commonly used for general anesthesia, while adjunctive agents (e.g., opioids, lidocaine, midazolam, and volatile anesthetics) are often used to supplement the effects of the primary anesthetic. Agents Lidocaine remains the most widely used local anesthetic in the United States, but all of these agents have comparable efficacy. Propofol is the most commonly used IV general anesthetic; at low doses, it induces sleep by allowing the patient to breathe on their own and is often used by anesthesiologists in addition to anxiolytics and analgesics.
Novocaine is a safe and effective local anesthetic used in dentistry for procedures that take less than 90 minutes, and several factors affect Novocaine retention time, including the use of epinephrine, Commonly used amino amides is contain lidocaine, mepivacaine, prilocaine, bupivacaine, etidocaine, and ropivacaine and levobupivacaine, commonly used amino esters include cocaine, procaine, tetracaine, chloroprocaine, and benzocaine. The safest form of anesthesia is local anesthesia, an injection of medication that numbs a small area of the body where the procedure is being performed; rarely, the patient experiences pain or itching where the medication is injected. Local anesthesia is where a small part of the body is numbed and you are fully conscious, often used for minor procedures, while general anesthesia is where you are completely unconscious and unaware of the procedures used for more serious operations. When used in dentistry, local anesthesia involves the injection of an anesthetic solution adjacent to the nerve that provides sensation in the area of the oral cavity where the treatment will be performed.
The demand for local anesthesia in the industry is driven by several factors, the local anesthesia pharmaceuticals market is expected to grow during the forecast period, due to growth in surgery and advances in computer-based drug delivery. Local anesthetic delivery and vibrotactile devices. An increase in the number of surgical procedures worldwide, including dental procedures, cosmetic surgeries, and plastic surgeries, is a major factor driving the local anesthetics market.
Local Anesthesia Drugs Market Dynamics
The growth of local anesthesia drugs market is driven by various factors such as increasing number of surgeries such as dental procedures, cosmetic surgery and plastic surgery, new approval of anesthetic drugs and increasing use of local anesthetics in postoperative pain. And others, the growing geriatric population and advancements in technology, and the approval of new anesthetic drugs and the expanded use of local anesthetics in postoperative pain are driving the expansion of the local anesthesia pharmaceuticals market. Increase in the development of novel local anesthetics and high demand for local anesthetics is expected to drive the growth of the local anesthetics market during the forecast period. For example, in December 2021, Hikma Pharmaceuticals PLC announced the launch of Bupivacaine HCI Injection. Bupivacaine HCI Injection is indicated for the preparation of local anesthesia or analgesia in adults, dental and oral surgery, diagnostic and therapeutic procedures, and obstetric procedures. Additionally, during the forecast period, high cost of processing and branded drugs will hamper the market growth. Lack of awareness among the general public is also a condition that negatively affects the market of anesthesia drugs and the side effects of these drugs and strict regulatory framework are expected to restrict the studied market.
Technological advancement
Advances in drug delivery technology are also expected to contribute to the demand for local anesthetics in surgery. Additionally, technological advancements in drug delivery, particularly development of targeted drugs, development of devices to monitor patient's physiological parameters during and after anesthesia, and reduced side effects of anesthesia are factors driving the market growth. In December 2022, Heron Therapeutics, Inc., a commercial-stage biotechnology company, focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, In December it announced the submission of a supplemental new drug application for ZYNRELEF (bupivacaine and meloxicam) to support the proposed indications for ZYNRELEF's widely expanded use in soft tissue and orthopedic surgical procedures, and a newly passed congressional bill that opposes it. To provide separate reimbursement outside of packaged surgical payments for ZYNRELEF for nearly 3 years. Manufactures involved in Local Anesthesia Drugs Market are developing advanced versions of their products due to new age technological advancements. Key players of Local Anesthesia Drugs are investing more in power systems and creating more modern, timesaving, cost-effective technology that has a positive impact on the Local Anesthesia Drugs Market
Local Anesthesia Drugs Market Segmentation
The Local Anesthesia Drugs Market is segmented based on drugs type, application, and route of administration, end user and region.
On the basis of drugs type, the Local Anesthesia Drugs Market is segmented into Bupivacaine, Lidocaine, Benzocaine, Ropivacaine, Prilocaine, Chloroprocaine, and Other Drug. On the basis of application, the target market is classified into General Surgeries, Plastic Surgery, Cosmetic Surgeries, Others. On the basis of route of administration, the Local Anesthesia Drugs Market is segmented into Inhalation, intravenous, others. On the basis of end user, the target market is classified into Hospital, Ambulatory Surgical Centers.
Regional Insights:
On region the Local Anesthesia Drugs Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market and is expected to maintain its dominance over the forecast period. North America accounts for the largest share of the market as high per capita income in the US, improved access to healthcare, rise in prevalence of chronic diseases, and growing aging population are fueling the market for local anesthesia. Medicines in this region
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Drugs Type - Bupivacaine, Lidocaine, Benzocaine, Ropivacaine, Prilocaine, Chloroprocaine, and Other Drug By Application - General Surgeries, Plastic Surgery, Cosmetic Surgeries, Others Route Of Administration - Inhalation, intravenous, Others By End User - Hospital, Ambulatory Surgical Centers |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Local Anesthesia Drugs Market report based on drug type, application, and route of administration, end user and region.
Local Anesthesia Drugs Market, By Drugs Type:
- Bupivacaine
- Lidocaine
- Benzocaine
- Ropivacaine
- Prilocaine
- Chloroprocaine
- Other Drug
Local Anesthesia Drugs Market, By Application:
- General Surgeries
- Plastic Surgery
- Cosmetic Surgeries
- Others
Local Anesthesia Drugs Market, By Route of Administration:
- Inhalation
- Intravenous
- Others
Local Anesthesia Drugs Market, By End User:
- Hospital
- Ambulatory Surgical Centers
Local Anesthesia Drugs Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Local Anesthesia Drugs Market Key Players
The key players operating the Local Anesthesia Drugs Market includes, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals, Abbott Pharmaceuticals, Pacira Pharmaceuticals, Inc., Pfizer Inc., Septodont, Baxter International Inc., Sagent Pharmaceutical, Inc., Teva Pharmaceuticals, Aspen Pharmacare, Mylan.
Local Anesthesia Drugs Market Company Profile
Company Profile:
- Fresenius SE & Co. KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hikma Pharmaceuticals
- Abbott Pharmaceuticals
- Pacira Pharmaceuticals, Inc.
- Pfizer Inc.
- Septodont
- Baxter International Inc.
- Sagent Pharmaceutical, Inc.
- Teva Pharmaceuticals
- Aspen Pharmacare
- Mylan
“*” marked represents similar segmentation in other categories in the respective section
Recent Developments:
- In March 2021, Pacira Biosciences, Inc., an industry leader in its commitment to non-opioid pain management and reproductive health solutions, announced in March that the US Food and Drug Administration has approved the submission of a Complementary New Drug Application to expand its The EXPAREL label includes the use of a single-dose infusion to produce postsurgical local analgesia in patients 6 years of age and older.
- In July 2021, Hikma Pharmaceuticals PLC, an international pharma company, launched succiniylcholine chloride injection, USP 20mg/ml in the US through its US subsidiary, Hikma pharmaceuticals USA Inc. Launched by Succiniylcholine Chloride Injection, USP plays an important role in the treatment of Covid-19 patients.
Local Anesthesia Drugs Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Route Of Administrations
- Key Thickness Insights
- Secondary Data
- Major Secondary Route Of Administrations
- Secondary Route Of Administrations
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drugs Type
- Market Snippet, By Application
- Market Snippet, By Route Of Administration
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Drugs Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Bupivacaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Lidocaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Benzocaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Ropivacaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Prilocaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Chloroprocaine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Other Drug
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By Application
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- General Surgeries
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Plastic Surgery
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cosmetic Surgeries
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By Route Of Administration
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Inhalation
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Intravenous
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Market Segmentation, By End User, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Drugs Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Route Of Administration, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Drugs Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Route Of Administration, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Drugs Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Route Of Administration, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Drugs Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Route Of Administration, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Drugs Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Route Of Administration, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Fresenius SE & Co. KGaA
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hikma Pharmaceuticals
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Pharmaceuticals
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pacira Pharmaceutical, Inc.
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Septodont
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Baxter International Inc.
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sagent Pharmaceuticals, Inc.
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Teva Pharmaceuticals
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Aspen Pharmacare
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mylan
- Company Overview
- Drugs Application Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Local Anesthesia Drugs Market is segmented based on drugs type, application, and route of administration, end user and region.
The growth of local anesthesia drugs market is driven by various factors such as increasing number of surgeries such as dental procedures, cosmetic surgery and plastic surgery, new approval of anesthetic drugs and increasing use of local anesthetics in postoperative pain.
North America dominates the market and is expected to maintain its dominance over the forecast period.
Key players operating in the Local Anesthesia Drugs Market includes, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals, Abbott Pharmaceuticals, Pacira Pharmaceuticals, Inc., Pfizer Inc., Septodont, Baxter International Inc., Sagent Pharmaceutical, Inc., Teva Pharmaceuticals, Aspen Pharmacare, Mylan.